 |
|
 |
|
|
location: |
Show all  |
|
tumor:
All tumors |
|
trial number(s) |
|
phase:
n/a |
|
status
nation wide:
n/a |
|
All sites |
 |
 |
 |
| - All sites |
|
CKTO 2004-06 |
|
III |
|
open (01-04-2005) |
 |
 |
 |
| - All sites |
|
PAZI, EMC 2008-245 |
|
I |
|
closed (24-11-2011) |
 |
 |
 |
| - All sites |
|
Clavis Pharma CP4126-111 |
|
I |
|
open (26-02-2009) |
 |
 |
 |
| - All sites |
|
GDC-0941, Genentech, INC. GDC4626g |
|
I |
|
open (09-11-2009) |
 |
 |
 |
| - All sites |
|
PANOBINOSTAT, LBH589, Novartis CLBH589X2105 |
|
I |
|
open (01-07-2010) |
 |
 |
 |
| - All sites |
|
Hoffmann - La Roche BP25385 |
|
I |
|
open (12-07-2011) |
 |
 |
 |
| - All sites |
|
Novartis CLEE011X2101 |
|
I |
|
open (15-07-2011) |
 |
 |
 |
| - All sites |
|
NKI-AvL M10PKS |
|
I |
|
open (15-07-2011) |
 |
 |
 |
Blood, Bone Marrow & Lymph Nodes |
 |
 |
 |
| - Non-Hodgkin Lymphoma |
|
CKTO 2006-07,HOVON 75 |
|
II |
|
open (24-04-2007) |
 |
 |
 |
| - Non-Hodgkin Lymphoma |
|
CKTO 2006-11,HOVON 80 |
|
II |
|
closed (04-11-2011) |
 |
 |
 |
| - Non-Hodgkin Lymphoma |
|
CKTO 2006-14,HOVON 84 |
|
III |
|
open (25-10-2007) |
 |
 |
 |
| - Non-Hodgkin Lymphoma |
|
CKTO 2007-10,HOVON 85 |
|
II |
|
open (15-08-2008) |
 |
 |
 |
| - Non-Hodgkin Lymphoma |
|
ACT-1, HOVON 90,KWF 2008-4247 |
|
III |
|
reopen (03-12-2009) |
 |
 |
 |
| - Non-Hodgkin Lymphoma |
|
ACT 2, DSHNHL 2006-1B , HOVON 91,KWF 2008-4248 |
|
III |
|
reopen (29-09-2010) |
 |
 |
 |
| - Non-Hodgkin Lymphoma |
|
ORCHARRD, GSK OMB110928,HOVON 98 |
|
III |
|
open (28-12-2009) |
 |
 |
 |
| - Non-Hodgkin Lymphoma |
|
HOVON 105,KWF 2009-4589 |
|
III |
|
open (01-10-2010) |
 |
 |
 |
| - Plasma Cell Tumors |
|
CKTO 2007-09,HOVON 86 |
|
I/II |
|
closed (23-01-2012) |
 |
 |
 |
| - Plasma Cell Tumors |
|
HOVON 87,KWF 2008-4246 |
|
III |
|
open (02-03-2009) |
 |
 |
 |
| - Plasma Cell Tumors |
|
REMM, Janssen-Cilag 2008.215 |
|
II |
|
open (05-03-2009) |
 |
 |
 |
| - Plasma Cell Tumors |
|
HOVON 95,KWF 2010-4798 |
|
III |
|
open (21-01-2011) |
 |
 |
 |
|
|
|
[1-20] van 125 |
|
|
 |
 |
Na inloggen verschijnen hier de werkgroepen waar u lid van bent.
|
 |